FindTrial
Sign In

Attitude and willingness of Chinese adults with rheumatic diseases to receive COVID-19 vaccination

Attitude and willingness of Chinese adults with rheumatic diseases to receive COVID-19 vaccination

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049502
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-07-19
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:willingness of COVID-19 vaccination

Sponsors

Department of rheumatology,Shenzhen Futian Hospital for Rheumatic Diseases
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. The respondent is an adult rheumatism diagnosed patient of Chinese nationality; 2. Age range: 18-60 years old; 3. Those who can clearly know their own diagnosis; 4. Basic reading and comprehension skills.

Exclusion criteria

Exclusion criteria: Researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Vaccination rate;—

Countries

China

Contacts

Public ContactZeng Huiqiong

Department of rheumatology,Shenzhen Futian Hospital for Rheumatic Diseases

zenghuiqiong0529@163.com+86 15986686048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026